← Back to Screener
Labcorp Holdings Inc. (LH)
Price$269.19
Favorite Metrics
Price vs S&P 500 (26W)-9.58%
Price vs S&P 500 (4W)-6.33%
Market Capitalization$22.18B
P/E Ratio (Annual)25.31x
Indicated Dividend Yield (Annual)1.07%
All Metrics
P/CF (Annual)13.52x
Book Value / Share (Quarterly)$104.86
P/TBV (Annual)4.14x
Indicated Dividend (Annual)$2.88
Revenue Growth (3Y)5.55%
Cash Flow / Share (Quarterly)$14.67
Payout Ratio (TTM)27.46%
Price vs S&P 500 (YTD)3.37%
Gross Margin (TTM)28.76%
Net Profit Margin (TTM)6.28%
EPS (TTM)$10.46
10-Day Avg Trading Volume0.55M
EPS Excl Extra (TTM)$10.46
Revenue Growth (5Y)-0.04%
EPS (Annual)$10.46
Dividend / Share (Annual)$2.91
ROI (Annual)6.14%
Gross Margin (Annual)28.76%
Net Profit Margin (5Y Avg)8.87%
Cash / Share (Quarterly)$6.48
P/E Basic Excl Extra (TTM)25.31x
Revenue Growth QoQ (YoY)5.60%
EPS Growth (5Y)-8.01%
P/E Normalized (Annual)25.31x
ROA (Last FY)4.77%
Revenue Growth TTM (YoY)7.25%
EBITD / Share (TTM)$19.74
ROE (5Y Avg)12.11%
Operating Margin (TTM)9.92%
Cash Flow / Share (Annual)$14.67
P/B Ratio2.57x
P/B Ratio (Quarterly)2.41x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.96x
Net Interest Coverage (TTM)5.18x
ROA (TTM)4.85%
EPS Growth QoQ (YoY)16.10%
EV / EBITDA (TTM)16.51x
EPS Incl Extra (Annual)$10.46
Current Ratio (Annual)1.42x
Quick Ratio (Quarterly)0.99x
3-Month Avg Trading Volume0.66M
52-Week Price Return23.98%
EV / Free Cash Flow (Annual)22.64x
P/E Incl Extra (TTM)25.31x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$61.12
P/S Ratio (Annual)1.59x
Asset Turnover (Annual)0.76x
52-Week High$293.72
Operating Margin (5Y Avg)11.91%
EPS Excl Extra (Annual)$10.46
CapEx CAGR (5Y)2.63%
Tangible BV CAGR (5Y)-1.43%
26-Week Price Return-2.69%
Quick Ratio (Annual)0.99x
13-Week Price Return0.11%
Total Debt / Equity (Annual)0.66x
Current Ratio (Quarterly)1.42x
Enterprise Value$27,301.256
Revenue / Share Growth (5Y)3.14%
Asset Turnover (TTM)0.77x
Book Value / Share Growth (5Y)1.78%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)19.34x
Pretax Margin (Annual)7.94%
Cash / Share (Annual)$6.48
3-Month Return Std Dev24.20%
Gross Margin (5Y Avg)30.71%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-9.35%
EBITDA Interim CAGR (5Y)-24.87%
ROE (Last FY)10.17%
Net Interest Coverage (Annual)5.16x
EPS Basic Excl Extra (Annual)$10.46
P/FCF (TTM)16.89x
Receivables Turnover (TTM)6.40x
EV / Free Cash Flow (TTM)22.64x
Total Debt / Equity (Quarterly)0.66x
EPS Incl Extra (TTM)$10.46
Receivables Turnover (Annual)6.40x
ROI (TTM)6.18%
P/S Ratio (TTM)1.59x
Pretax Margin (5Y Avg)10.48%
Revenue / Share (Annual)$166.49
Tangible BV / Share (Annual)$61.12
Forward P/E15.08x
Free OCF CAGR (5Y)-7.21%
Price vs S&P 500 (52W)-10.65%
P/E Ratio (TTM)25.31x
EPS Growth TTM (YoY)18.34%
Year-to-Date Return7.30%
5-Day Price Return0.12%
EPS Normalized (Annual)$10.46
ROA (5Y Avg)5.87%
Net Profit Margin (Annual)6.28%
Month-to-Date Return0.89%
Cash Flow / Share (TTM)$13.73
EBITD / Share (Annual)$19.72
EPS Growth (3Y)-9.18%
Operating Margin (Annual)9.92%
LT Debt / Equity (Annual)0.59x
P/CF (TTM)13.52x
ROI (5Y Avg)7.56%
P/E Excl Extra (TTM)25.31x
LT Debt / Equity (Quarterly)0.59x
EPS Basic Excl Extra (TTM)$10.46
P/TBV (Quarterly)4.14x
Payout Ratio (Annual)27.46%
P/B Ratio (Annual)2.41x
Dividend / Share (TTM)$2.91
Inventory Turnover (TTM)19.34x
Pretax Margin (TTM)7.94%
Book Value / Share (Annual)$104.86
Price vs S&P 500 (13W)-2.27%
Net Margin Growth (5Y)-10.81%
Dividend Yield (TTM)1.09%
Beta0.97x
P/FCF (Annual)18.39x
Revenue / Share (TTM)$167.69
ROE (TTM)10.28%
52-Week Low$209.38
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.14
4.14
Industry Peers — Health Services(20)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
LHLabcorp Holdings Inc. | 25.31x | 7.25% | 9.92% | 10.28% | $269.19 |
NTRANatera, Inc. Common Stock | — | 35.90% | -13.44% | -15.28% | $207.74 |
DGXQuest Diagnostics Inc. | 21.75x | 11.78% | 14.10% | 13.88% | $196.31 |
EXASExact Sciences Corp | — | 17.69% | -6.35% | -8.51% | $104.91 |
GHGuardant Health, Inc. Common Stock | — | 32.88% | -45.02% | -246.60% | $91.07 |
RDNTRadNet, Inc. Common Stock | 1779.27x | 11.51% | 3.04% | -1.88% | $57.85 |
VCYTVeracyte, Inc. | 39.66x | 16.01% | 11.17% | 5.33% | $33.45 |
GRALGRAIL, Inc. Common Stock | — | 17.18% | -381.98% | -17.11% | $51.20 |
CDNACareDx, Inc. | 18.34x | 13.79% | -8.10% | -6.47% | $21.29 |
FTREFortrea Holdings Inc. Common Stock | — | 1.00% | -32.04% | -152.17% | $10.44 |
CSTLCastle Biosciences, Inc. Common Stock | 47.31x | 3.66% | -12.44% | -5.27% | $25.16 |
About
Labcorp is one of the two largest independent clinical laboratory companies in the United States, commanding approximately 20% of the independent lab market. The company operates roughly 2,000 patient-service centers and offers a comprehensive suite of 5,000 clinical tests, from routine blood and urine analysis to advanced oncology and genomic testing.